COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines



EMA and ECDC have reviewed currently available studies and epidemiological data to provide a common position for EU/EEA countries on the current need and potential benefit of a fourth dose (second booster dose) of mRNA COVID-19 vaccines.